chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a healthcare worker via a company representative refers to a patient of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date the reporter stated that patient had previously received one dose of PREVNAR 13 on an unspecified date, inadvertently received a second dose of PNEUMOVAX 23 (dosing details were not reported) (wrong vaccine administered). No concomitant medications were reported. No adverse effects were reported. There was no product quality complaint involved. Additional information is not expected as the reporter did not wish further contact.
Systemic: Dizziness / Lightheadness-Severe, Additional Details: After getting pfizer vaccine, patient was waiting in the observation area. Patient started to complain of lightheadness and was about to fell off the chair, so the observer catched him and helped lay him down flat onto the floor, while calling 911. Pt was totally consious and confirmed no trouble with breathing, just lightheadness. The paramedic came and took him to the hospital for further checkup.
terrible tinnitus after receiving your vaccine; This is a spontaneous report from a contactable consumer. This consumer reported same event in two patients. This is the second of two reports. A consumer (patients husband) reported that his wife of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unknow date in 2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. After receiving the vaccine the patient experienced terrible tinnitus in 2021. The patient has been to the doctor once including an ENT visit. The reporter told CDC and they don't care. The doctors just shrug. It's nowbeen 5 months with no improvement. The outcome of the event was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101102231 Same drug/AE, different patient
Shoulder Related Vaccine Administration Injury. Pt unable to range the arm and with pain in the arm. This occurred within 1-2 days of getting the injection. Pt was referred and seen by ortho.  MRI was ordered.   We have not heard updates since.
Hives from head to toe and tightness of throat.  Provider gave me a Decadron (steroid shot) and high dose oral prednisone. Even with shot and oral steroids it took 5 days for the hives to go away and another 4 days for my throat to feel normal again.
1 day post vaccination patient started to feel joint pain in her knees which is unusual for her with no hx of joint issues. the pain was significant enough to cause difficulty ambulating. 1 week post vaccine she is still c/o some tightness and discomfort. she has also noticed hives and itching on her knees and thighs, along with night sweats.
PT. HAD THE FIRST VARICELLA & CONTRACTED CHICKEN POX. SHE WAS DIAGNOSED TODAY IN THE OFFICE.
Information has been received from a physician concerning a 13 week old male, with no significant medical history, who on 10/11/06 was vaccinated with a first 2.0 ml oral dose of Rotavirus vaccine. concomitant vaccines administered on the same day included a dose of Prevnar, Dtap, ActHib, Hep B. On 10/31/06 the pt had three episodes of yellow vomiting and was fussy. On 11/17/06 the pt presented to the physicians office with acute persistent vomiting and pallor. The physician indicated that the pt looked sickly. the pt was hospitalized that same day. Hemoglobin on admission was 34. An abdominal X ray revealed bowel gas and an upper gastrointestinal series was normal. Intentions were to send the pt home as he seemed to be doing fine. Hemoglobin had decreased to 28 post hydration. the pt subsequently began to vomit again and he remained hospitalized. All labs were normal with the exception of a slightly increased white blood cell count of about 16000. Stool tests were neg (not further specified), but were guaiac positive. the physician indicated that the stools were not grossly bloody. The pt subsequently recovered and was discharged from the hospital (exact date was not known) with a diagnosis of gastroenteritis and dehydration. The reporter indicated that, although he suspected the event to be a case of intussusception, he could not be sure as no formal diagnosis of intussusception was made during the hospitalization as no Barium enema was performed. he also noted that the second dose of Rotavirus vaccine would not be administered. At the time of the report the pt was noted to be doing fine. The physician indicated that he would provide additional information, including medical records, if it became available. Additional information has been requested. 01/24/07-records received from facility for DOS 11/17-11/19/06 DC DX: gastroenteritis resolved versus milk protein allergy vomiting resolved Mild anemia Acute onset vomiting at 1500 on 11/1/706. Became bilious. KUB showed a paucity of bowel gas. GI performed:normal. In ER after hydration, improvement noted but at DC had foul smelling stool and vomited all Pedialyte and barium. Admitted.  After admission hematocrit decreased from 34 to 26 over approximatley 16 hours. PE:WNL.
Gave adult dose to pediatric patient. Patient waited 15 minutes after injection  and no adverse reaction at injection site. Immediately following injection immunization team was informed. They informed me no other actions needed to be taken other than reporting incident.
Pt did not respond to series of vax;  Recv booster dose & lab data showed no titers.  Pt (EBU91023) had no titer following 3 doses + 1 booster dose.
SOME SIDE EFFECTS; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On MAR-2021, the subject experienced some side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of some side effects was not reported. This report was non-serious. This case, from the same reporter.
Skin appears to be raised, diameter of about 1 cm. The affected area is sore, however area around is not.
Weakness- lasted two days then diminished, muscle ache mostly in legs- lasted one or two days, chills- occurred for one or two days. This is the fourth dose- no problems occurred with the previous three doses.
was vaccinated / still got them/ Suspected Vaccination failure; got them; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles vaccine and got the shingle. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Tachycardia HR>100 at rest, going up to 140?s-150?s with movement. Seen in the ED and was sinus tachycardia with some T wave inversions in the EKG. Tachycardia improved the following days and worsened day again day 7-12 after vaccination. Cardiac work up was done, including ECHO and C-CTA that was negative. Tachycardia self resolved after day 12 post vaccine. It was associated with fatigue and i ability to perform daily tasks. Had to take off from work and rest.
Dizziness immediately after when I stood up.  Within fifteen minutes increased heart rate and breathing, shortness of breath, and lips having a weird feeling.  At 10 pm sore throat and injection site soreness.
Patient came to the pharmacy on 2/11 at around 5 pm and said that yesterday at around 9 pm she started to get bad pain around the shoulder and neck. She also reported chills and said that her lymph nodes were significantly inflamed. She was visibly in pain at the pharmacy on 2/11 when she reported the pain. Her doctor told her to put ice on it and take ibuprofen and if there is no improvement to come in for an appointment in a couple of days. Muscle pain after a vaccine is a common side effect but this was significantly worse. I am not sure if she had an allergic reaction of some sort to the vaccine.
I am pregnant, due 7/11/21. Healthy singleton pregnancy (4th child).  I am not actually positive when I first noticed, but I have a red circle around the area where I received my vaccine. It is is 1.5 inches by 2.25 inches. It is slightly swollen and red. Sometimes it is more visible than others. It is slightly tender to the touch but does not itch.
Developed severe chills an hour after she received vaccine.  Reports fever for 2 days (did not check temperature).  Continued to have mild weakness, nausea, mild body aches for almost 10 days. Daughter reported she fell out of bed and was confused.
This spontaneous report was received from a certified medical assistant and concerns an unspecified number of patients of unknown age and gender. No medical history or concurrent conditions were reported. On unknown dates, the patients were vaccinated with improperly stored M-M-R II (having lot # reported as L020188 and expiration date as 03-JUN-2017) (dose number, dosage and route of administration were not reported). No concomitant therapies were reported. No previous excursions had occurred. This temperature excursion occurred at 50 F for a time frame of one hour. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
Autoinoculation of left hand, single lesion, identified on 03/05/03.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided. On 10-JUL-2017, the patient was vaccinated with improperly stored dose of ZOSTAVAX lot # N012493, expiration 17-MAR-2018 (dose and route of administration were not reported) for prophylaxis. No adverse event reported. Temperature: 15 degrees Fahrenheit (°F) to 46°F . Time Frame: 12 hours 19 minutes. No previous temperature excursion. Digital Data logger report was involved. Additional information has been requested.
I began to have some skipped heart beats; This is a spontaneous report from a contactable consumer (patient). This is 1st of two reports. A 86-years-old male patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL3248, expiry date not reported) via an unspecified route of administration on 13Jan2021 (at the age of 86-years-old) as a 1st dose, single for COVID 19 immunisation.The patient medical history included skipped heartbeats and was taking a medicine (Unspecified medication), that for 4 years and it had been working. Concomitant medication were not reported. On an unspecified date, the patient began to have some skipped heart beats. The patient was supposed to take the second dose on 02Feb2021. He did not have any skipped heart beats with the unspecified medication he used but after the vaccination, he began to have some skipped heart beats. The outcome of the event was unknown.   Consumer was informed about Pfizer Medical information department and was unwilling to complete the report, hence further probing could not be done. Limited information was available over the call.  Follow-up attempts are completed. No further information is expected.
12 year old individual presented to the health dept for their 2nd Pfizer monovalent dose. A Pfizer bivalent dose was given instead of a Pfizer monovalent dose.
Patient states she woke up Saturday 07/20/19, and her vision was blurry in both eyes. She said it was difficult to see close at first. Throughout the day it became harder to see further away. Eventually all aspects of her vision were blurry.  She never lost her sight completely. Each day her vision has improved she said. However as of 07/23/19 her vision is still not back to normal.
Jul2020 you had COVID - fatigue , shortness of breath and  did not lose sense of smell. very thirsty and headaches and body aches. all these symptoms subsided in after my 2nd dose and it returned in Jul/Aug2021. Did not test for COVID in Jul/Aug2021.  Saw doctor in Aug2021 referred to COVID clinic  for long haul COVID symptoms. I had the 3rd booster - still have fatigue. body aches
No adverse effects. Mother had taken child to the clinic for flu shot and was also scheduled at the school for shot. Form was not pulled as mother did not inform the school that she had taken the child to the clinic for flu shot.
An attorney reported that a 65 year old female received either IPV or OPV (manuf unk) in the 1950s. She was reportedly diagnosed with mesothelioma on or about May 2000. It is alleged that, exposure to SV40 in the vaccine was a cause of the pt's mesothilioma. The reporter also noted exposure to asbestos and asbestos containing products as a cause. No further info was available at the date of this report.
This is a spontaneous report received from a contactable consumer (Patient). A 40-years-old male patient received third booster dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration, administered in Arm right on 28Oct2021 13:15 (at the age of 40-years-old) as dose 3 (booster), single for covid-19 immunisation and also received covid-19 vaccine (mrna 1273) (MODERNA COVID-19 VACCINE, Batch/Lot number: Unknown), via an unspecified route of administration, administered in Arm left on 28Oct2021 as dose 3 (booster), single for covid-19 immunisation. Medical history included colitis ulcerative, allergy from kiwi, penicillin from an unknown date, and unknown if ongoing. Concomitant medications received within two weeks included MESALAMINE and POLYETHYLENE GLYCOL both taken for an unspecified indication, start and stop date were not reported for any. The patient previously received first dose of moderna covid-19 vaccine on 17Mar2021 (at the age of 39-years-old) for covid-19 immunisation and received second dose of moderna covid-19 vaccine administered in arm right on 07Apr2021 (at the age of 40-years-old) for covid-19 immunisation and also received Cefdinir and experienced drug hypersensitivity. Patient received vaccine facility in public health clinic/veterans. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient denied for any other vaccine in four weeks. On 29Oct2021 01:00, the patient had severe diarrhea, similar to colonoscopy prep for which patient drank plenty of water but still was weak, lightheaded and could not sleep the entire night due to complications. The reporter considered the event as non-serious. It was reported that ae resulted in emergency room/department or urgent care for examination. The patient did not received any treatment for the events. The patient underwent lab tests and procedures which included examination with unknown results on an unspecified date. The outcome of the events was reported as recovering. Lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected
The patient's spouse reported the patient had a sore arm that has continued since receiving the injection and she is now unable to raise her arm. The pharmacist called the patient and encouraged her to go to urgent care to have this checked out to rule out SIRVA. The patient saw provider. The provider did not think the problem was SIRVA. She thought it was a rotator cuff injury. The provider gave the patient a muscle relaxant and NSAID and exercises.
This case was reported by a healthcare professional and described the occurrence of swollen leg in a 2-year-old male subject who was vaccinated with HAVRIX adult (GlaxoSmithKline). On 10 August 2010 the subject received a dose of HAVRIX adult (details unknown), and experienced overdose. On either 10 or 11 August 2010, the same day or 1 day after vaccination with HAVRIX adult, the subject experienced swollen leg. At the time of reporting the outcome of the events was unspecified.
sick as a dog; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported for a female patient (granddaughter) that: A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single and received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Caller states that his granddaughter was a nurse practitioner and she had both of her covid vaccine shots, and his daughter she also got the vaccine, they were both sick as a dog, they were both sick for 2 days. Caller stated that he has no Lot number or Expiry date to provide for the vaccine that his daughter and granddaughter received, he does not live with them. The outcome of the event was unknown.   Information about Batch/Lot number has been requested.   Follow-up attempts completed. No further information expected.
woke from nap screaming, high pitched cry @ home;inj site w/6-7cm swelling
injection site is red about the size of a quarter.; Rash come back; went to emergency room -gave her allergy medication and it got better; redness of arm; Chills; Nausea; has not done well with it; redness of arm/ 48 hours later developed a rash on neck, arm and chest; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (has not done well with it), RASH ERYTHEMATOUS (redness of arm/ 48 hours later developed a rash on neck, arm and chest), VACCINATION SITE ERYTHEMA (injection site is red about the size of a quarter.), HYPERSENSITIVITY (went to emergency room -gave her allergy medication and it got better) and ERYTHEMA (redness of arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042LL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced DISCOMFORT (has not done well with it), RASH ERYTHEMATOUS (redness of arm/ 48 hours later developed a rash on neck, arm and chest), ERYTHEMA (redness of arm), CHILLS (Chills) and NAUSEA (Nausea). On 29-Jan-2021, the patient experienced HYPERSENSITIVITY (went to emergency room -gave her allergy medication and it got better). On 11-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site is red about the size of a quarter.) and RASH (Rash come back). At the time of the report, DISCOMFORT (has not done well with it), RASH ERYTHEMATOUS (redness of arm/ 48 hours later developed a rash on neck, arm and chest), VACCINATION SITE ERYTHEMA (injection site is red about the size of a quarter.), HYPERSENSITIVITY (went to emergency room -gave her allergy medication and it got better), ERYTHEMA (redness of arm), CHILLS (Chills), RASH (Rash come back) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Concomitant medications were not provided.
singles; This case was reported by a consumer via  interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a day after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided are as follows: The case reported by patient for himself/herself. Age at vaccination was not reported. The patient received a dose of Shingles vaccine and got shingles within 24 hours after vaccination. Shingles were ultimately cured with home remedies within six months. The follow up would not be possible as no contact details were available.
pt recv vax 12JUN97 & 21JUN 8PM pt started w/low grade fever is not-up to 102;rash started 22JUN97 w/red dots splotchy face;highest fever 102;
severe spine pain; felt really tired; could not get out of bed; exhausted; arm a little red; chills; arm sore; fever; slept the entire next day; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of BACK PAIN (severe spine pain), MALAISE (felt really tired), FATIGUE (could not get out of bed; exhausted), INJECTION SITE ERYTHEMA (arm a little red) and CHILLS (chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 038k20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included ASCORBIC ACID, FOLIC ACID, IRON, RETINOL, ZINC (SUPLEMENTO DE MICRONUTRIENTES), VITAMINS NOS, LEVOTHYROXINE and ALBUTEROL SULFATE for an unknown indication.   On 24-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced BACK PAIN (severe spine pain), MALAISE (felt really tired), FATIGUE (could not get out of bed; exhausted), INJECTION SITE ERYTHEMA (arm a little red), CHILLS (chills), PAIN IN EXTREMITY (arm sore), PYREXIA (fever) and FATIGUE (slept the entire next day). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 500 milligram. At the time of the report, BACK PAIN (severe spine pain), MALAISE (felt really tired), FATIGUE (could not get out of bed; exhausted), INJECTION SITE ERYTHEMA (arm a little red), CHILLS (chills), PAIN IN EXTREMITY (arm sore), PYREXIA (fever) and FATIGUE (slept the entire next day) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
Left arm feel numb from injection site down including palm and fingers.  Can not feel things when touch.  Patient is currently away at school.  Will visit physician during brake in mid-December